Its synthesis was part of an effort to develop an efficient antagonist against the glucocorticoid receptors (GR), which could be used to alleviate the consequences of excess glucocorticoid activity in patients with hypercortisolism (Baulieu 1997). The gene discussed is NR3C1; the disease is adrenal gland hyperfunction.